drugset / Trial / NCT02721186

Summary

The overall aim of this study is to determine the effectiveness of two rounds of mass drug administration (MDA) with dihydroartemisinin-piperaquine (DHAp) + single low dose (SLD) primaquine for reducing seasonal malaria transmission in Shehias considered hotspots on Unguja Island, Zanzibar.

Timeline

Start
2016-04-30
Primary completion
2016-12-31
Completion
2017-09-30

Outcome

Missed primary endpoint

paper No difference in cumulative malaria case incidence was observed between the control and intervention arms 6 months post-MDA (4.2 and 3.9 per 1000 population; p = 0.94). PMID 30526588 ↗

paper Neither was there a difference in PCR-determined parasite prevalences 3 months post-MDA (1.4% and 1.7%; OR = 1.0, p = 0.94) PMID 30526588 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dihydroartemisinin-piperaquine Unknown — —
Subject Primaquine Small molecule 0.25 mg/kg —

Indications